Identification of an Adamantyl Azaquinolone JNK Selective Inhibitor
ACS Medicinal Chemistry Letters2012Vol. 3(9), pp. 764–768
Citations Over TimeTop 13% of 2012 papers
Nancy-Ellen Haynes, Nathan R. Scott, Li C. Chen, Cheryl A. Janson, Jiakui Li, Christine Lukacs, Aruna Railkar, Effie Tozzo, Toni Whittard, Nicholas F. Brown, Adrian Wai‐Hing Cheung
Abstract
3-[4-((1S,2S,3R,5S,7S)-5-Hydroxyadamantan-2-ylcarbamoyl)benzyl]-4-oxo-1-phenyl-1,4-dihydro-[1,8]naphthyridine-2-carboxylic acid methyl ester (4) was identified as a novel, druglike and selective quinolone pan JNK inhibitor. In this communication, some of the structure-activity relationship of the azaquinolone analogues leading to 4 is discussed. The focus is on how changes at the amide functionality affected the biochemical potency, cellular potency, metabolic properties, and solubility of this class of JNK inhibitors. Optimization of these properties led to the identification of the adamantyl analogue, 4. 4 achieved proof of mechanism in both rat and mouse TNF-α challenge models.
Related Papers
- → STKVS: secure technique for keyframes-based video summarization model(2024)7 cited
- Study and Two Types of Typical Usage of DataGrid Web Server Control(2005)
- Using DataGrid Control to Realize DataBase of Querying in VB6.0(2000)
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → ИСПОЛЬЗОВAНИЕ ПОТЕНЦИAЛA СОЦИAЛЬНЫХ ПAРТНЕРОВ В ПОДГОТОВКЕ БУДУЩИХ ПЕДAГОГОВ(2024)